First study on Factor V Leiden detection in Nicaraguan patients with unprovoked venous thromboembolism: Preliminary report
ISSN 2250-8309 (versión en línea) - ISSN 0329-0379 (versión impresa)
pdf (Español (España))

Keywords

factor V Leiden, genetic thrombophilia, venous thromboembolism

How to Cite

Montealegre, L., Ruiz, W., Estrada, S., García, K., Santamaría, C., Puller, A., & Pernudy, A. (2019). First study on Factor V Leiden detection in Nicaraguan patients with unprovoked venous thromboembolism: Preliminary report. Journal of Hematology, 22(2), 193–196. Retrieved from https://revistahematologia.com.ar/index.php/Revista/article/view/27

Abstract

Factor V Leiden (FVL) is the most common genetic thrombophilia. It is constituted by the substitution of a guanine by an adenine in nucleotide 1691 of the gene coding for the coagulation factor V. As a result, the regulatory mechanisms of hemostasis are altered with predominance of procoagulant mechanisms. A cross-sectional study was carried out in 21 patients with a diagnosis of unprovoked vein thromboembolism. The processing of the biological samples was performed by polymerase chain reaction -  restriction fragment length polymorphism (PCR-RFLP). The FVL was detected in 14.3% of studied patients, all with heterozygous genotype. This preliminary report is the first study on Nicaraguan patients with venous thrombosis and the observed FVL frequency is comparable with previous reports from Latin America countries.

pdf (Español (España))

References

1. Hernández H, Usme S, Yunis, J. Genotipos frecuentemente asociados a trombofilias. Biomédica. 2014; 34(1):132-142.
2. Bertina R, Koeleman B, Koster T y col. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994 Mayo; 369 (1): 64- 67.
3. Venegas M, Conte G, Cuneo M. Detección de las mutaciones Factor V Leiden y Protrombina G20210A en Pacientes con Trombosis Venosa. Revista HCUCh. 2006; 17(1):141-147.
4. López T, Delgado V, Puentes D y col. Frecuencia de la mutación del Factor V Leiden y protrombina G2021A en pacientes con tromboembolismo venoso. Revista de la Facultad de Ciencias de la Salud. 2007; Diciembre; 11 (3): 33-41.
5. Altuna D, Ceresetto J, Fassi D y col. Trombofilias. Hematología. 2012; 42 (1): 473,481.
6. Tirado M. Análisis de la trombofilia hereditaria: Contribución de factores genéticos en la predisposición al tromboembolismo venoso en la población española. [Tesis para optar al grado de Doctor en Farmacia]. España. Universitat de Barcerlona; 2004. Disponible en: http://diposit.ub.edu/dspace/bitstream/2445/36618/1/TESIS_ISABEL_TIRADO.pdf
7. Kujovich J. Factor V Leiden thrombophilia. Genet Med. 2011; 13 (1):1-16.
8. Iglesias M, Adamczuk Y, Forastiero R y col. Major and Potential Prothrombotic Genotypes in a Cohort of Patients With Venous Thromboembolism. Thrombosis Research. 2001; 104(1): 317-324.
9. Huber S, McMaster K, Voelkerding K. Analytical Evaluation of Primer Engineered Multiplex Polymerase Chain Reaction–Restriction Fragment Length Polymorphism for Detection of Factor V Leiden and Prothrombin G20210A. Journal of Molecular Diagnostics. 2000; 2 (3): 153-157.
10. Torres J, Cardona H, Alvarez L y col. Inherited Thrombophilia is Associated With Deep Vein Thrombosis in a Colombian Population. American Journal of Hematology. 2006; 81(1): 933-937.
11. Srur E, Vargas C, Salas S y col. Trombofilia primaria: detección y manifestación clínica en 105 casos. Rev Méd Chile. 2004; 132(1): 1466-1473.
12. Méndez M, Salazar L, Porras J. Trombofilia primaria: Mejorando el diagnóstico basado en evidencia. Rev Costarr Cardiol. 2013; 15 (2): 25-30.

All material published in the journal HEMATOLOGÍA (electronic and print version) is transferred to the Argentinean Society of Hematology. In accordance with the copyright Act (Act 11 723), a copyright transfer form will be sent to the authors of approved works, which has to be signed by all the authors before its publication. Authors should keep a copy of the original since the journal is not responsible for damages or losses of the material that was submitted. Authors should send an electronic version to the email: revista@sah.org.ar

Downloads

Download data is not yet available.